News Feed

A new pilot study explored whether adding ibuprofen to treatment for drug-resistant tuberculosis (TB) could improve patient outcomes. While the anti-inflammatory drug did not increase cure rates or improve lung recovery compared with standard TB therapy alone, researchers found it reduced several inflammatory markers linked to severe disease. These findings suggest ibuprofen may help regulate the body's immune response, although this did not translate into better clinical results in the small trial. Experts believe the low dose and limited number of participants may have influenced the outcome. Larger placebo-controlled studies are now needed to determine whether higher doses or similar host-directed therapies can improve treatment for drug-resistant TB.

A new Dutch study suggests that switching to a plant-based diet without careful planning may reduce intake of important nutrients, especially in older adults and teenagers. Researchers found that replacing common animal-based foods with plant-based alternatives lowered protein, essential amino acids, vitamin B12, calcium, iodine, selenium, and zinc intake, even when healthier plant-based options were chosen. While folate, vitamin E, and non-heme iron increased, some nutrients still remained below recommended levels. The findings highlight that plant-based diets can offer major health and environmental benefits, but choosing fortified foods and well-balanced protein sources is essential to avoid nutritional deficiencies during the transition.

New research published in Nature Communications suggests that Alzheimer's disease may first impair cognitive flexibility—the brain's ability to adapt, learn new rules, and adjust to changing situations—months before memory loss becomes noticeable. Using animal models, scientists found that overactive brain circuits linked to decision-making disrupted flexible thinking while memory remained intact. Encouragingly, calming these hyperactive pathways restored cognitive function and reduced amyloid-beta buildup, a hallmark of Alzheimer's disease. Although the findings still need confirmation in humans, they highlight cognitive flexibility as a promising early marker for diagnosis and a potential target for treatments aimed at slowing disease progression before irreversible brain damage occurs.

Researchers have developed a promising new CAR T-cell therapy that precisely targets the CALR mutation, a key driver of myeloproliferative neoplasms (MPNs)—a group of rare blood cancers. Unlike current treatments that mainly control symptoms, this therapy is designed to eliminate the cancer stem cells responsible for disease progression while leaving healthy blood cells unharmed. In laboratory studies, patient samples and mouse models, the engineered immune cells successfully destroyed CALR-mutant cancer cells, even within scarred bone marrow. Researchers also found that combining the therapy with eltrombopag enhanced its cancer-killing ability in advanced disease. A Phase I clinical trial is planned, offering hope for longer-lasting remissions and potentially curative treatment for patients with CALR-mutated MPNs.

A new study suggests that the strongest emotional and physiological connection between a music therapist and patient typically develops about 25 minutes into a therapy session. Researchers monitored heart-rate synchrony in patients undergoing neurorehabilitation and found that alignment between therapist and patient gradually increased, peaking between 20 and 25 minutes. Higher synchrony is associated with greater empathy and more productive therapy sessions. Interestingly, patients' heart rates often led these moments of connection, highlighting their active role in the therapeutic process. The findings suggest that shorter therapy sessions may not allow enough time for meaningful therapeutic synchrony to develop, although larger studies are still needed.

Researchers have identified a brain circuit that may explain why severe stress interferes with the brain's ability to suppress traumatic memories, a key feature of post-traumatic stress disorder (PTSD). The study found that stress activates the locus coeruleus, which disrupts activity in the brain's prefrontal cortex through the amygdala, impairing fear extinction—the process that helps people overcome traumatic memories. Blocking specific beta receptors in the amygdala restored this ability in animal models, suggesting a potential new treatment strategy. The findings also indicate that the timing of exposure therapy is crucial, as administering it too soon after trauma may reduce its effectiveness.

A new scientific review suggests that gut microbes could play an important role in the development and treatment of estrogen-driven cancers, including breast and endometrial cancer. Researchers found that the gut microbiome can regulate estrogen metabolism, produce hormone-like compounds, and influence inflammation and immune responses, all of which may affect cancer risk and progression. The review also highlights emerging microbiome-based therapies, such as probiotics, prebiotics, live biotherapeutics, and targeted microbial treatments, as potential future strategies. However, current evidence is largely based on laboratory and observational studies. Larger clinical trials are needed before microbiome-guided therapies can become part of routine cancer care.

Earwax does more than protect your ears—it may also provide clues about your overall health. Scientists have found that changes in its color, texture, and smell can sometimes reflect infections, metabolic disorders, skin conditions, or even chronic diseases. For example, unusually greasy earwax has been linked to Parkinson's disease, while foul-smelling or green earwax may signal an ear infection. Researchers are also exploring whether compounds in earwax could help detect conditions such as diabetes and certain cancers in the future. However, experts emphasize that earwax alone cannot diagnose disease. Persistent pain, hearing loss, unusual discharge, or a strong odor should always be evaluated by a healthcare professional.

Researchers have identified a promising link between gut health and lupus, an autoimmune disease in which the immune system attacks healthy tissues. A new study found that people with lupus have lower levels of Faecalibacterium prausnitzii, a beneficial gut bacterium known for producing anti-inflammatory compounds. In animal studies, restoring this bacterium reduced disease markers and improved immune regulation, offering hope for future treatments. Scientists believe the microbe helps maintain a healthy gut barrier and reduces inflammation by supporting fiber digestion. Although more human research is needed, the findings highlight the growing role of the gut microbiome in autoimmune diseases and the potential for targeted probiotic therapies.

Occasionally waking up during the night is normal, but consistently waking around 3 AM may signal an underlying health condition. Doctors say sleep disorders such as obstructive sleep apnea, asthma, COPD, diabetes, thyroid problems, menopause, or hormonal imbalances can all disrupt sleep at the same time each night. Warning signs like loud snoring, gasping for air, morning headaches, excessive daytime fatigue, night sweats, or frequent urination should not be ignored. Persistent sleep disruption can also increase the risk of heart disease, high blood pressure, and poor mental health. If this pattern continues for several weeks, experts recommend seeking medical evaluation to identify and treat the root cause.